Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension
JACC: Heart Failure · 2024
DOI: 10.1016/j.jchf.2024.04.015 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Thenappan Thenappan. Beteiligte Einrichtung: Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: tthenapp@umn.edu. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Arginine, Endothelium, Vascular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: tthenapp@umn.edu.
Zitieren
APA
Thenappan, T. (2024). Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.04.015
Vancouver
Thenappan T. Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2024.04.015
BibTeX
@article{Thenappan2024,
author = {Thenappan, Thenappan},
title = {Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension},
journal = {JACC: Heart Failure},
year = {2024},
doi = {10.1016/j.jchf.2024.04.015}
}
EUVIMED